Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients
- PMID: 23910690
- DOI: 10.1016/j.jaci.2013.05.039
Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients
Abstract
Background: Chronic granulomatous disease (CGD) is a rare primary immunodeficiency disorder of phagocytes resulting in impaired killing of bacteria and fungi. A mutation in one of the 4 genes encoding the components p22(phox), p47(phox), p67(phox), and p40(phox) of the leukocyte nicotinamide dinucleotide phosphate reduced (NADPH) oxidase leads to autosomal recessive (AR) CGD. A mutation in the CYBB gene encoding gp91(phox) leads to X-linked recessive CGD.
Objective: The aim of this study is to show the correlation between clinical, functional, and genetic data of patients with CGD from Turkey.
Methods: We report here the results of 89 patients with CGD from 73 Turkish families in a multicenter study.
Results: Most of the families (55%) have an AR genotype, and 38% have an X-linked genotype; patients from 5 families with a suspected AR genotype (7%) were not fully characterized. We compared patients with CGD according to the severity of NADPH oxidase deficiency of neutrophils. Patients with A22(0), A67(0) or X91(0) phenotypes with a stimulation index of 1.5 or less have early clinical presentation and younger age at diagnosis (mean, 3.2 years). However, in p47(phox)-deficient cases and in 5 other AR cases with high residual oxidase activity (stimulation index ≥ 3), later and less severe clinical presentation and older age at diagnosis (mean, 7.1 years) were found. Pulmonary involvement was the most common clinical feature, followed by lymphadenitis and abscesses.
Conclusion: Later and less severe clinical presentation and older age at diagnosis are related to the residual NADPH oxidase activity of neutrophils and not to the mode of inheritance. CGD caused by A22(0) and A67(0) subtypes manifests as severe as the X91(0) subtype.
Keywords: A22 CGD with residual oxidase activity; A22(R); AR; Autosomal recessive; CGD; CYBA; CYBB; Chronic granulomatous disease; DHR; Dihydrorhodamine-1,2,3; MFI; Mean fluorescence intensity; NADPH; NBT; NCF1; NCF2; Nicotinamide dinucleotide phosphate reduced; Nitroblue tetrazolium; PMA; Phagocyte oxidase; Phorbol 12-myristate 13-acetate; ROI; Reactive oxygen intermediate; SI; Stimulation index; X-CGD; X-linked recessive chronic granulomatous disease; dihydrorhodamine-1,2,3 assay; mean fluorescence intensity; nicotinamide dinucleotide phosphate reduced oxidase; phox; stimulation index.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Comment in
-
The long road to optimal management for chronic granulomatous disease.J Allergy Clin Immunol. 2013 Nov;132(5):1164-5. doi: 10.1016/j.jaci.2013.08.035. Epub 2013 Oct 4. J Allergy Clin Immunol. 2013. PMID: 24094546 No abstract available.
Similar articles
-
Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.J Allergy Clin Immunol. 2003 Feb;111(2):374-9. doi: 10.1067/mai.2003.58. J Allergy Clin Immunol. 2003. PMID: 12589359
-
Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease.Clin Immunol. 2008 Aug;128(2):117-26. doi: 10.1016/j.clim.2008.05.008. Clin Immunol. 2008. PMID: 18625437
-
Genetic and biochemical background of chronic granulomatous disease.Arch Immunol Ther Exp (Warsz). 2004 Mar-Apr;52(2):113-20. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15179325 Review.
-
Mutations of chronic granulomatous disease in Turkish families.Eur J Clin Invest. 2007 Jul;37(7):589-95. doi: 10.1111/j.1365-2362.2007.01828.x. Eur J Clin Invest. 2007. PMID: 17576211
-
Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.Pediatr Allergy Immunol. 2016 May;27(3):242-53. doi: 10.1111/pai.12527. Epub 2016 Jan 21. Pediatr Allergy Immunol. 2016. PMID: 26680691 Review.
Cited by
-
Two CGD Families with a Hypomorphic Mutation in the Activation Domain of p67phox.J Clin Cell Immunol. 2014 Jun 30;5(3):1000231. J Clin Cell Immunol. 2014. PMID: 25937994 Free PMC article.
-
Molecular diagnosis of chronic granulomatous disease.Clin Exp Immunol. 2014 Feb;175(2):139-49. doi: 10.1111/cei.12202. Clin Exp Immunol. 2014. PMID: 24016250 Free PMC article. Review.
-
Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India.J Clin Immunol. 2017 Apr;37(3):319-328. doi: 10.1007/s10875-017-0382-x. Epub 2017 Mar 22. J Clin Immunol. 2017. PMID: 28332028
-
Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience.J Clin Immunol. 2021 Jul;41(5):992-1003. doi: 10.1007/s10875-021-01002-w. Epub 2021 Feb 24. J Clin Immunol. 2021. PMID: 33629196
-
Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry.J Allergy Clin Immunol Pract. 2022 May;10(5):1325-1333.e5. doi: 10.1016/j.jaip.2021.12.035. Epub 2022 Jan 14. J Allergy Clin Immunol Pract. 2022. PMID: 35033700 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous